Atlas Trials

Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

Clinical trial NCT01425294 · TERMINATED

Trial details

NCT number
NCT01425294
Sponsor
AstraZeneca
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2011-08-01
Primary completion
2016-01-30
Enrollment
231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.